These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11927180)

  • 21. Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys: antagonism and apparent pA2 analyses.
    Li JX; Rice KC; France CP
    J Pharmacol Exp Ther; 2009 Mar; 328(3):976-81. PubMed ID: 19098164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain.
    Adlersberg M; Arango V; Hsiung S; Mann JJ; Underwood MD; Liu K; Kassir SA; Ruggiero DA; Tamir H
    J Neurosci Res; 2000 Sep; 61(6):674-85. PubMed ID: 10972964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of the 5-HT(2C) receptor antagonist SB242,084 on behaviour produced by the 5-HT(2) agonist Ro60-0175 and the indirect 5-HT agonist dexfenfluramine.
    Higgins GA; Ouagazzal AM; Grottick AJ
    Br J Pharmacol; 2001 Jun; 133(4):459-66. PubMed ID: 11399662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissociable effects of selective 5-HT2A and 5-HT2C receptor antagonists on serial spatial reversal learning in rats.
    Boulougouris V; Glennon JC; Robbins TW
    Neuropsychopharmacology; 2008 Jul; 33(8):2007-19. PubMed ID: 17957219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes.
    Newman-Tancredi A; Cussac D; Quentric Y; Touzard M; Verrièle L; Carpentier N; Millan MJ
    J Pharmacol Exp Ther; 2002 Nov; 303(2):815-22. PubMed ID: 12388668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonism at 5-HT(2A) receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats.
    Wadenberg MG; Browning JL; Young KA; Hicks PB
    Pharmacol Biochem Behav; 2001 Mar; 68(3):363-70. PubMed ID: 11325387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 5-HT2A receptor antagonist M100,907 attenuates motor and 'impulsive-type' behaviours produced by NMDA receptor antagonism.
    Higgins GA; Enderlin M; Haman M; Fletcher PJ
    Psychopharmacology (Berl); 2003 Nov; 170(3):309-319. PubMed ID: 12904968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of serotonin (5-HT)(1B) receptor ligands, microinjected into accumbens subregions, on cocaine discrimination in rats.
    Filip M; Papla I; Nowak E; Jungersmith K; Przegaliński E
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Sep; 366(3):226-34. PubMed ID: 12172705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of 5-hydroxytryptamine 2A (5-HT2A) receptors in the mediation of the discriminative stimulus properties of (+/-)DOI in rats.
    Chojnacka-Wójcik E; Kłodzińska A
    Pol J Pharmacol; 1997; 49(5):299-304. PubMed ID: 9566028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
    Thomsen WJ; Grottick AJ; Menzaghi F; Reyes-Saldana H; Espitia S; Yuskin D; Whelan K; Martin M; Morgan M; Chen W; Al-Shamma H; Smith B; Chalmers D; Behan D
    J Pharmacol Exp Ther; 2008 May; 325(2):577-87. PubMed ID: 18252809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An immunocapture/scintillation proximity analysis of G alpha q/11 activation by native serotonin (5-HT)2A receptors in rat cortex: blockade by clozapine and mirtazapine.
    Mannoury La Cour C; Chaput C; Touzard M; Millan MJ
    Synapse; 2009 Feb; 63(2):95-105. PubMed ID: 19016481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of serotonin (5-HT) 5-HT2 receptor subtypes to the discriminative stimulus effects of cocaine in rats.
    Filip M; Bubar MJ; Cunningham KA
    Psychopharmacology (Berl); 2006 Jan; 183(4):482-9. PubMed ID: 16261316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats.
    Fantegrossi WE; Harrington AW; Kiessel CL; Eckler JR; Rabin RA; Winter JC; Coop A; Rice KC; Woods JH
    Pharmacol Biochem Behav; 2006 Jan; 83(1):122-9. PubMed ID: 16460788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New serotonin 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptor antagonists: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo and heterocycloalkanones.
    Brea J; Rodrigo J; Carrieri A; Sanz F; Cadavid MI; Enguix MJ; Villazón M; Mengod G; Caro Y; Masaguer CF; Raviña E; Centeno NB; Carotti A; Loza MI
    J Med Chem; 2002 Jan; 45(1):54-71. PubMed ID: 11754579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
    Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
    J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptor.
    Smith RL; Barrett RJ; Sanders-Bush E
    J Pharmacol Exp Ther; 1995 Nov; 275(2):1050-7. PubMed ID: 7473132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S-16924, a novel, potential antipsychotic with marked serotonin1A agonist properties. IV. A drug discrimination comparison with clozapine.
    Millan MJ; Schreiber R; Monneyron S; Denorme B; Melon C; Queriaux S; Dekeyne A
    J Pharmacol Exp Ther; 1999 Apr; 289(1):427-36. PubMed ID: 10087034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(+/-)DOI] in C57BL/6J mice.
    Smith RL; Barrett RJ; Sanders-Bush E
    Psychopharmacology (Berl); 2003 Feb; 166(1):61-8. PubMed ID: 12474110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of 5-HT2A receptor stimulation on the discrimination of durations by rats.
    Asgari K; Body S; Bak VK; Zhang ZQ; Rickard JF; Glennon JC; Fone KC; Bradshaw CM; Szabadi E
    Behav Pharmacol; 2006 Feb; 17(1):51-9. PubMed ID: 16377963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.